Skip to main content
SpringerLink
Log in

Does attainment of target levels of growth hormone and insulin-like growth factor I improve acromegaly prognosis?

  • Practice Point
  • Published:

From Nature Clinical Practice Endocrinology & Metabolism

View current issue Sign up to alerts

Abstract

For almost a decade, treatment goals for acromegaly have been those recommended by an expert group—achievement of serum growth hormone (GH) levels <2.5 µg/l and age-adjusted, normal levels of insulin-like growth factor I (IGF-I). This Practice Point commentary discusses a meta-analysis by Holdaway et al. that investigated the relationship between mortality and levels of GH and IGF-I in patients with acromegaly. The findings of the study confirm that the current criteria are adequate in terms of mortality, and that the prognosis of acromegaly has improved in the past 20 years. This improvement may be related to the comparatively aggressive treatment of the disease and management of comorbidities. Changes in the methods used by clinicians to measure GH levels probably require new criteria to be adopted, as good control of acromegaly is now more adequately defined as serum GH levels <1 µg/l and age-adjusted normal levels of IGF-I.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Giustina A et al. (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85: 526–529

    CAS  PubMed  Google Scholar 

  2. Holdaway IM et al. (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 159: 89–95

    Article  CAS  Google Scholar 

  3. Kauppinen-Makelin R et al. (2005) A nationwide survey of mortality in acromegaly. J Clin Endocrinol Metab 90: 4081–4086

    Article  Google Scholar 

  4. Colao A et al. (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25: 102–152

    Article  CAS  Google Scholar 

  5. Nachtigall L et al. (2008) Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab 93: 2035–2041

    Article  CAS  Google Scholar 

  6. Maison P and Chanson P (2006) Less is more risky? Growth hormone and insulin-like growth factor I levels and cardiovascular risk. Nat Clin Pract Endocrinol Metab 2: 650–651

    Article  Google Scholar 

  7. Cazabat L et al. (2008) Dynamic tests for the diagnosis and assessment of treatment efficacy in acromegaly. Pituitary 11: 129–139

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. P Chanson is Professor of Endocrinology at the University Paris-Sud 11 and Head of the Service of Endocrinology and Reproductive Disease in Bicêtre Hospital, Le Kremlin-Bicêtre, France.,

    Philippe Chanson

  2. P Maison is Assistant Professor of Clinical Pharmacology at University Paris 12 and Head of the Clinical Research Unit of Henri Mondor Hospital, Créteil, France.,

    Patrick Maison

Authors
  1. Philippe Chanson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick Maison
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philippe Chanson.

Ethics declarations

Competing interests

Philippe Chanson received consulting and lecture fees and grant/research support from Novartis, Ipsen and Pfizer. Patrick Maison declared no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chanson, P., Maison, P. Does attainment of target levels of growth hormone and insulin-like growth factor I improve acromegaly prognosis?. Nat Rev Endocrinol 5, 70–71 (2009). https://doi.org/10.1038/ncpendmet1048

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet1048

  • Springer Nature Limited

This article is cited by

Search

Navigation